Literature DB >> 20398933

Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating.

Hongwei Chen1, Liya Wang, Julie Yeh, Xinying Wu, Zehong Cao, Yongqiang A Wang, Minming Zhang, Lily Yang, Hui Mao.   

Abstract

One of the major limitations impeding the sensitivity and specificity of biomarker targeted nanoparticles is non-specific binding by biomolecules and uptake by the reticuloendothelial system (RES). We report the development of an antibiofouling polysiloxane containing amphiphilic diblock copolymer, poly(ethylene oxide)-block-poly(gamma-methacryloxypropyl trimethoxysilane) (PEO-b-PgammaMPS), for coating and functionalizing high quality hydrophobic nanocrystals such as iron oxide nanoparticles and quantum dots. These PEO-b-PgammaMPS-coated nanocrystals were colloidally stable in biological medium and showed low non-specific binding by macromolecules after incubation with 100% fetal bovine serum. Both in vitro experiments with macrophages and in vivo biodistribution studies in mice revealed that PEO-b-PgammaMPS copolymer-coated nanocrystals have an antibiofouling effect that reduces non-specific cell and RES uptake. Surface functionalization with amine groups was accomplished through co-crosslinking the polysiloxane coating layer and (3-Aminopropyl)trimethoxysilane in aqueous solution. Tumor integrin alpha(v)beta(3) targeting peptide cyclo-RGD ligands were conjugated on the nanoparticles through a heterobifunctional linker. The resulting integrin alpha(v)beta(3) targeting nanoparticle conjugates showed improved cancer cell targeting with a stronger affinity to U87MG glioma cells, which have a high expression of alpha(v)beta(3) integrins, but minimal binding to MCF-7 breast cancer cells with low expression of alpha(v)beta(3) integrins. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398933      PMCID: PMC2878482          DOI: 10.1016/j.biomaterials.2010.03.036

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  35 in total

1.  Synthesis of compact multidentate ligands to prepare stable hydrophilic quantum dot fluorophores.

Authors:  H Tetsuo Uyeda; Igor L Medintz; Jyoti K Jaiswal; Sanford M Simon; Hedi Mattoussi
Journal:  J Am Chem Soc       Date:  2005-03-23       Impact factor: 15.419

Review 2.  Quantum dots for live cells, in vivo imaging, and diagnostics.

Authors:  X Michalet; F F Pinaud; L A Bentolila; J M Tsay; S Doose; J J Li; G Sundaresan; A M Wu; S S Gambhir; S Weiss
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

3.  The preparation of colloidally stable, water-soluble, biocompatible, semiconductor nanocrystals with a small hydrodynamic diameter.

Authors:  Emma E Lees; Tich-Lam Nguyen; Andrew H A Clayton; Benjamin W Muir; Paul Mulvaney
Journal:  ACS Nano       Date:  2009-05-26       Impact factor: 15.881

4.  A facile approach to fabricate functionalized superparamagnetic copolymer-silica nanocomposite spheres.

Authors:  Dechao Niu; Yongsheng Li; Xiaoli Qiao; Liang Li; Wenru Zhao; Hangrong Chen; Qiaoling Zhao; Zhi Ma; Jianlin Shi
Journal:  Chem Commun (Camb)       Date:  2008-07-29       Impact factor: 6.222

5.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.

Authors:  C Chouly; D Pouliquen; I Lucet; J J Jeune; P Jallet
Journal:  J Microencapsul       Date:  1996 May-Jun       Impact factor: 3.142

6.  Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers.

Authors:  William W Yu; Emmanuel Chang; Joshua C Falkner; Junyan Zhang; Ali M Al-Somali; Christie M Sayes; Judah Johns; Rebekah Drezek; Vicki L Colvin
Journal:  J Am Chem Soc       Date:  2007-02-20       Impact factor: 15.419

7.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Authors:  Chunfu Zhang; Manfred Jugold; Eva C Woenne; Twan Lammers; Bernd Morgenstern; Margareta M Mueller; Hanswalter Zentgraf; Michael Bock; Michael Eisenhut; Wolfhard Semmler; Fabian Kiessling
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.

Authors:  Kai Chen; Jin Xie; Hengyi Xu; Deepak Behera; Mark H Michalski; Sandip Biswal; Andrew Wang; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2009-09-20       Impact factor: 12.479

9.  Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice.

Authors:  Tapan K Jain; Susan P Foy; Bernadette Erokwu; Sanja Dimitrijevic; Christopher A Flask; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2009-09-17       Impact factor: 12.479

10.  Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings.

Authors:  Brad A Kairdolf; Michael C Mancini; Andrew M Smith; Shuming Nie
Journal:  Anal Chem       Date:  2008-03-07       Impact factor: 6.986

View more
  42 in total

1.  Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.

Authors:  Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary
Journal:  ACS Nano       Date:  2013-08-20       Impact factor: 15.881

2.  Multifunctional nanomedicines: potentials and prospects.

Authors:  Udita Agrawal; Madhu Gupta; Rajesh S Jadon; Rajeev Sharma; S P Vyas
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 3.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

Review 4.  Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.

Authors:  Lei Zhu; Zhiyang Zhou; Hui Mao; Lily Yang
Journal:  Nanomedicine (Lond)       Date:  2016-11-23       Impact factor: 5.307

5.  Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells.

Authors:  Leyuan Xu; Shannon Kittrell; W Andrew Yeudall; Hu Yang
Journal:  Nanomedicine (Lond)       Date:  2016-10-26       Impact factor: 5.307

Review 6.  Nanoscale interfaces to biology.

Authors:  Sunho Park; Kimberly Hamad-Schifferli
Journal:  Curr Opin Chem Biol       Date:  2010-07-30       Impact factor: 8.822

7.  Uniform fluorescent nanobioprobes for pathogen detection.

Authors:  Ling-Hong Xiong; Ran Cui; Zhi-Ling Zhang; Xu Yu; Zhixiong Xie; Yun-Bo Shi; Dai-Wen Pang
Journal:  ACS Nano       Date:  2014-05-02       Impact factor: 15.881

8.  Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.

Authors:  Liya Wang; Xiaodong Zhong; Weiping Qian; Jing Huang; Zehong Cao; Qiqi Yu; Malgorzata Lipowska; Run Lin; Andrew Wang; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2014-11       Impact factor: 4.813

9.  Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.

Authors:  Hayley J Paholak; Nicholas O Stevers; Hongwei Chen; Joseph P Burnett; Miao He; Hasan Korkaya; Sean P McDermott; Yadwinder Deol; Shawn G Clouthier; Tahra Luther; Qiao Li; Max S Wicha; Duxin Sun
Journal:  Biomaterials       Date:  2016-06-23       Impact factor: 12.479

10.  PEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.

Authors:  Yuancheng Li; Run Lin; Liya Wang; Jing Huang; Hui Wu; Guojun Cheng; Zhengyang Zhou; Tobey MacDonald; Lily Yang; Hui Mao
Journal:  J Mater Chem B       Date:  2015-04-02       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.